Reminder: SOR III, Year 2 Kickoff Meeting on October 10th

We wanted to remind you about the upcoming SOR III, Year 2 Kickoff meeting hosted by the OMNI SOR Treatment Evaluation Team.

Date: Tuesday, October 10th

Time: 11:00 a.m. - 12:00 p.m. ET

Registration Link (please register in advance): https://omni-org.zoom.us/meeting/register/tZYtd-qgqDgoH9BbF0SJ2ErJ6CkiftMBSgm4

The Kick-Off meeting presents an excellent opportunity for you to connect with OMNI, DBHDS, and other CSB/Agency teams to delve into important topics related to Year 2 of the SOR III grant period, which began October 1st. It’s important to note that the GPRA tools will not be changing for the new fiscal year. Yet, we wanted to share some information with you all about the following:

  • SOR III, Year 1 Overview

  • General Review of GPRA Information for Year 2

  • TA Resources & Communications

  • Upcoming GPRA Trainings

Additionally, this gathering will allow you to ask questions and share your experiences, successes, and challenges from the past year. The OMNI SOR team is excited to facilitate this community forum setting for learning and sharing.

Please remember that you will need to register in advance to receive the meeting link. You can register here or at the link above.

If you have any questions, please reach out to OMNI at SORSupport@omni.org. See you at the Kickoff!

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.